The tie up aims to deliver a target list of compounds suitable for taking forward for further development.
IVCC chief operating officer Tom McLean said this project joins their other discovery programmes aimed at developing three new active ingredients unaffected by known resistance mechanisms by 2020.
Scynexis president and CEO Yves Ribeill said they look forward to apply its technology and expertise to the delivery of compound candidates for effective mosquito control.